Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
About this item
Full title
Author / Creator
Von Hoff, Daniel D , Ervin, Thomas , Arena, Francis P , Chiorean, E. Gabriela , Infante, Jeffrey , Moore, Malcolm , Seay, Thomas , Tjulandin, Sergei A , Ma, Wen Wee , Saleh, Mansoor N , Harris, Marion , Reni, Michele , Dowden, Scot , Laheru, Daniel , Bahary, Nathan , Ramanathan, Ramesh K , Tabernero, Josep , Hidalgo, Manuel , Goldstein, David , Van Cutsem, Eric , Wei, Xinyu , Iglesias, Jose and Renschler, Markus F
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this report, the addition of nab-paclitaxel to standard gemcitabine increased the response rate, progression-free survival, and overall survival among patients with metastatic pancreatic adenocarcinoma.
Pancreatic cancer is the fourth leading cause of cancer-related death in Europe and the United States.
1
,
2
Since 1997, gemcitab...
Alternative Titles
Full title
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Authors, Artists and Contributors
Author / Creator
Ervin, Thomas
Arena, Francis P
Chiorean, E. Gabriela
Infante, Jeffrey
Moore, Malcolm
Seay, Thomas
Tjulandin, Sergei A
Ma, Wen Wee
Saleh, Mansoor N
Harris, Marion
Reni, Michele
Dowden, Scot
Laheru, Daniel
Bahary, Nathan
Ramanathan, Ramesh K
Tabernero, Josep
Hidalgo, Manuel
Goldstein, David
Van Cutsem, Eric
Wei, Xinyu
Iglesias, Jose
Renschler, Markus F
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4631139
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4631139
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1304369
